Your 90-Day AR Analysis is complimentary - See your true collection gap.
Oncology Billing Services

Chemotherapy Administration Coding Guidelines

Published Date - Mar 08, 2022 Modified Date - Nov 16, 2026 15 min read
Chemotherapy Administration Coding Guidelines

Chemotherapy administration coding guidelines decide which CPT code in the 96401–96549 range is billed for each drug, based on route, technique and documented infusion time. Only one initial code is reported per encounter unless a separate IV site is used. An infusion longer than 15 minutes is coded 96413, +96415 is added once it passes 90 minutes, and a second drug infused in sequence takes +96417. The drug itself is billed separately with its J-code and a JW or JZ modifier, while concurrent hydration, routine port flushes and CPT 99211 are bundled and not paid separately.

Key Takeaways

  • Chemotherapy administration coding guidelines allow only one initial service code (96360, 96365, 96374, 96409, 96413) per encounter unless separate IV sites are used.
  • Reporting two initial service codes for separate IV access sites requires the appropriate modifier.
  • Drug administration codes 96360–96379, 96401–96425, and 96521–96523 are billable by physicians only in office settings, not facilities.
  • Drug administration tied to Medicare-approved ASC procedures is not separately reportable by physicians.
  • CPT 99211 is bundled into chemotherapy administration codes, but 99202–99205 and 99212–99215 can be billed with modifier 25.
  • Port flushing before or after drug administration is integral to the service and should not be billed as CPT 96523.
  • CPT 96522 applies only to programmable implantable pumps and cannot be billed with 96416 or 96425, which include the initial pump fill.
  • CPT 96368 allows one unit per encounter for concurrent infusion, and hydration given with chemotherapy is not separately reportable.
  • Infusion codes are time-based: 96413 needs more than 15 minutes, and the first unit of +96415 applies at 91 minutes.
  • Single-dose drug lines billed to Medicare need the JW (wasted amount) or JZ (no waste) modifier, or the claim can be returned.

The Centers for Medicare & Medicaid Services (CMS) periodically publishes revised coding guidelines for CPT codes 90000 – 99999. In this Blog, we shared CPT codes applicable for Chemotherapy Administration Coding and minor updates in guidelines.

Chemotherapy Administration Coding Guidelines & CPT Rules

Chemotherapy Administration CPT Codes at a Glance (96401–96549)

Chemotherapy administration codes are built around route, technique and time, not the drug itself. The drug is billed on its own line with a HCPCS J-code. Infusion centers that treat the code family as one interchangeable block are the ones that see add-on codes denied and initial codes downcoded.

CPT code What it reports Notes
96401 Subcutaneous or intramuscular injection, non-hormonal anti-neoplastic Per injection
96402 Subcutaneous or intramuscular injection, hormonal anti-neoplastic E.g. leuprolide, goserelin, fulvestrant
96405 / 96406 Intralesional, up to 7 lesions / more than 7 lesions  
96409 IV push, single or initial substance Infusion of 15 minutes or less is a push
+96411 IV push, each additional substance Add-on to 96409 or 96413
96413 IV infusion, up to 1 hour, single or initial substance Requires more than 15 minutes
+96415 IV infusion, each additional hour Billed when time runs more than 30 minutes past each hour
96416 Initiation of prolonged infusion (more than 8 hours) requiring a portable or implantable pump  
+96417 Each additional sequential infusion, different substance, up to 1 hour Once per sequential drug
96420 / 96422 / +96423 / 96425 Intra-arterial push / infusion up to 1 hour / each additional hour / prolonged infusion with pump  
96440 Into pleural cavity, requiring thoracentesis  
96446 Into peritoneal cavity via indwelling port or catheter  
96450 Into CNS (intrathecal), requiring spinal puncture  
96521 / 96522 Refill and maintenance of portable pump / implantable pump or reservoir  
96523 Irrigation of implanted venous access device Only when no other service is billed that day
96542 Into subarachnoid or intraventricular space via subcutaneous reservoir Single or multiple agents
96549 Unlisted chemotherapy procedure  

Which Drugs Qualify for Chemotherapy Administration Codes

The 964xx codes are not limited to cancer drugs. CPT allows them for anti-neoplastic agents and for other highly complex drugs and biologics that need advanced clinical oversight, such as monoclonal antibodies and biologic response modifiers. That means an infusion of rituximab for a rheumatology patient or methotrexate for a non-oncology indication can qualify, provided the payer recognizes the drug for chemotherapy administration and the record documents the monitoring involved.

Where groups lose money is in the opposite direction: billing complex biologics under the lower-paying therapeutic infusion codes (96365–96368) out of caution. Many Medicare Administrative Contractors publish lists of non-chemotherapy drugs that may be reported with chemotherapy administration codes, so the check is payer-specific. Antiemetics, steroids, hydration and supportive drugs given alongside chemotherapy never move into the 964xx range; they stay in the therapeutic, prophylactic and hydration codes (96360–96379).

Reporting Initial Service Code

The CPT codes 96360, 96365, 96374, 96409, and 96413 describe ‘initial’ service codes. For a patient encounter, only 1 ‘initial’ service code may be reported unless it is medically reasonable and necessary that the drug or substance administrations occur at separate intravenous access sites. To report 2 different ‘initial’ service codes, you can use appropriate modifiers.

When a second initial code is reported for a separate IV access site, append modifier XS (or 59, if the payer does not accept X modifiers) and document both sites.

Infusion Hierarchy: Physician Office vs Hospital Outpatient

When one encounter includes chemotherapy, a therapeutic drug and hydration, only one service can be billed as “initial.” Which one gets that status depends on who is billing.

Hospital outpatient departments billing under OPPS follow a fixed hierarchy, regardless of the order the drugs were hung: chemotherapy infusion → chemotherapy push → therapeutic/prophylactic infusion → therapeutic push → hydration.

Physicians billing in the office (non-facility) select the initial code based on the primary reason for the encounter, not the hierarchy and not the clock. In most oncology visits that is still the chemotherapy drug, but the reasoning has to be documented.

Every other service in the encounter is then reported as sequential, concurrent or additional-hour add-on codes. Hydration is the most common casualty: it is billable as 96360/96361 only when it is medically necessary and not given concurrently with chemotherapy or another infusion, and it must run more than 30 minutes to count.

Time Rules for 96409, 96413, 96415 and 96417

Chemotherapy infusion codes are time-based, so the start and stop times in the infusion record decide which code and how many units are payable.

  • 15 minutes or less: report as a push (96409, or +96411 for each additional drug).
  • 16 to 90 minutes: one unit of 96413.
  • 91 to 150 minutes: 96413 + 1 unit of +96415.
  • 151 to 210 minutes: 96413 + 2 units of +96415, and so on in hourly steps.

A second, different chemotherapy drug infused after the first is reported with +96417 for its first hour. If that second drug runs past 90 minutes, its extra time goes back to +96415. +96415 and +96417 are never billed without a primary code (96413) on the same claim.

Worked example: a first chemotherapy drug infused over 60 minutes followed by a second, different drug infused for 95 minutes is coded 96413 (first drug), +96417 (second drug, first hour) and +96415 x1 (the second drug’s extra 35 minutes qualify because they exceed 30 minutes).

Two errors drive most time-related losses: infusion records that say “completed” without a stop time, which forfeits every add-on unit, and counting pre-medication or flush time toward the chemotherapy infusion.

Using Correct POS

CPT codes 96360-96379, 96401-96425, and 96521-96523 are reportable by providers/suppliers for services performed in physicians’ offices. These drug administration services shall not be reported by providers/suppliers for services provided in a facility setting such as a hospital outpatient department or emergency department.

Drug administration services performed in an Ambulatory Surgical Center (ASC) related to Medicare-approved ASC payable procedures are not separately reportable by providers/suppliers. Hospital outpatient facilities may separately report drug administration services when appropriate.

The term ‘Physician’ in this article refers to M.D.s, D.O.s, and other practitioners who bill Medicare claims processing contractors for services payable on the MPFS (Medicare Physician Fee Schedule).

In practice, this means drug administration codes are billed by the physician for POS 11 (office), while POS 19 and 22 (off-campus and on-campus hospital outpatient) are billed by the facility under OPPS.

Billing CPT 99211

The drug and chemotherapy administration HCPCS/CPT codes 96360-96375, 96377 and 96401-96425 have been valued to include the work and practice expenses of CPT code 99211 (E&M service, office or other outpatient visit, established patient, level I).

Although CPT code 99211 is not reportable with chemotherapy and non-chemotherapy drug/substance administration HCPCS/CPT codes, other non-facility-based E&M CPT codes (e.g., 99202- 99205, 99212-99215) are separately reportable with modifier 25 if the physician provides a significant and separately identifiable E&M service.

Since providers/suppliers shall not report drug administration services in a facility setting, a facility-based E&M CPT code (e.g., 99281- 99285) shall not be reported with a drug administration CPT code unless the drug administration service is performed at a separate patient encounter in a non-facility setting on the same date of service. In such situations, the E&M code should be reported with modifier 25.

Under the OPPS (Outpatient Prospective Payment System), hospitals may report drug administration services and facility-based E&M codes (e.g., 99281-99285, G0463) if the E&M service is significant and separately identifiable. In these situations, modifier 25 should be appended to the E&M code.

These bundling rules remain current in the CMS NCCI Policy Manual revised January 1, 2026.

Inappropriate Use of CPT 96523

Flushing or irrigation of an implanted vascular access port or device prior to or subsequent to the administration of chemotherapeutic or non-chemotherapeutic drugs is integral to the drug administration service and is not separately reportable. Under these circumstances, do not report CPT code 96523.

Billing ‘refilling & maintenance of an implantable pump/reservoir for systemic drug delivery’

CPT code 96522 describes the refilling and maintenance of an implantable pump or reservoir for systemic drug delivery. The pump or reservoir must be capable of programmed release of a drug at a prescribed rate. CPT code 96522 shall not be reported for accessing a nonprogrammable implantable intravenous device for the provision of infusion(s) or chemotherapy administration.

CPT code 96522 (Refilling and maintenance of implantable pump or reservoir for drug delivery, systemic (e.g., intravenous, intra-arterial) and CPT code 96521 (Refilling and maintenance of portable pump) shall not be reported with CPT code 96416 (Initiation of prolonged intravenous chemotherapy infusion (more than 8 hours), requiring use of a portable or implantable pump) or CPT code 96425 (Chemotherapy administration, intra-arterial; infusion technique, initiation of prolonged infusion (more than 8 hours) requiring the use of a portable or implantable pump). CPT codes 96416 and 96425 include the initial filling and maintenance of a portable or implantable pump. CPT codes 96521 and 96522 are used to report subsequent refilling of the pump.

CPT codes 96521 and 96522 shall not be reported for accessing or flushing an indwelling peripherally-placed intravenous catheter port (external to skin), subcutaneous port, or nonprogrammable subcutaneous pump. Accessing and flushing these devices is an inherent service facilitating these infusion(s) and is not reported separately.

Billing CPT Code 96368

A concurrent intravenous infusion of an antiemetic or other non-chemotherapeutic drug with intravenous infusion of chemotherapeutic agents may be reported separately as CPT code 96368 (Concurrent intravenous infusion).

CPT code 96368 may be reported with a maximum of one unit of service per patient encounter regardless of the number of concurrently infused drugs or the length of time for the concurrent infusion(s). Hydration concurrent with chemotherapy is not separately reportable.

Billing the Drug Separately: J-Codes, Units and JW/JZ Modifiers

The administration code pays for the work of giving the drug. The drug itself, often the larger dollar line on an oncology claim, is billed separately with its HCPCS Level II code (most chemotherapy agents fall in J9000–J9999), and units must match the code descriptor, not the vial size. A drug described “per 10 mg” given at 450 mg is 45 units; a single digit error on a high-cost biologic can turn a five-figure line into an overpayment finding.

For Medicare Part B drugs from single-dose containers, two modifiers apply:

  1. JW reports the discarded amount on its own claim line. Medicare has required it since January 1, 2017.
  2. JZ attests that nothing was discarded. CMS has required it since July 1, 2023, and claims missing JW or JZ on applicable drugs can be returned as unprocessable.

Both modifiers depend on the record showing the exact dose administered and the amount wasted. JW without wastage documentation is one of the easiest recoupments for an auditor to sustain.

ICD-10-CM Sequencing for Chemotherapy Encounters (Z51.11 / Z51.12)

When the visit is solely for chemotherapy, Z51.11 (encounter for antineoplastic chemotherapy) is listed first, followed by the malignancy being treated. For immunotherapy-only visits, Z51.12 is the first-listed code. When both are given in the same encounter, both Z codes are reported, followed by the cancer diagnosis.

Two sequencing rules prevent most diagnosis-related denials:

  1. If the patient is still receiving treatment directed at the cancer, code the active malignancy (C code), not personal history (Z85).
  2. If the encounter is mainly to treat a complication, such as dehydration or anemia, and no chemotherapy is given, the complication is listed first, not Z51.11.

Diagnosis codes must also match the payer’s coverage policy for the drug. A correctly coded administration line will still deny if the drug’s LCD or NCD does not list the reported cancer diagnosis.

Documentation That Holds Up in a MAC or RAC Review

Medicare contractors look for the same set of records when they review chemotherapy administration claims. The infusion flowsheet or medication administration record should show, for every drug:

  • Drug name, dose, route and site
  • Start and stop time for each infusion and push
  • IV access site, with a note when a second site is used
  • Amount administered and amount discarded (to support JW/JZ)
  • Physician order and treatment plan supporting medical necessity
  • The physician’s separate E/M note, when modifier 25 is used
  • Supervision consistent with Medicare’s requirements for the setting

Nursing templates that force start time, stop time and route on every line prevent most time-based denials before the claim is built.

Common Chemotherapy Administration Denials and How to Prevent Them

Denial trigger What goes wrong Prevention
Missing stop time Add-on units (96415, 96417) denied Hard-stop fields in the infusion template
Wrong initial code Hierarchy ignored in facility claims, or wrong primary reason in office claims Pre-bill hierarchy edit by place of service
Two initial codes, one IV site Second initial code denied Only bill a second initial code with a separate site documented and modifier XS or 59
Unsupported modifier 25 E/M denied or recouped Separate, significant E/M note, not routine pre-chemo checks
Hydration billed concurrently 96360/96361 denied Bill hydration only when it runs alone and for more than 30 minutes
JW/JZ missing Claim returned as unprocessable Modifier edit on every single-dose drug line
Unit mismatch on J-code Overpayment or underpayment Units calculated from the HCPCS descriptor, not the vial
Diagnosis not covered by LCD/NCD Drug line denied Check drug policy before the first cycle
96523 billed with drug administration Line denied as integral Bill 96523 only when it is the only service that day

Medical Billers and Coders (MBC) is a leading medical billing company providing complete revenue cycle solutions. CPT® is a registered trademark of the American Medical Association (AMA).

We shared some CPT codes and their guidelines for reference purposes only. For accurate use, please refer to the detailed code descriptions. If you need assistance with chemotherapy administration coding, contact us at info@medicalbillersandcoders.com / 888-357-3226.

Want to know how many 96415 and 96417 units your infusion center is losing to missing stop times? Request a chemotherapy claims audit and our oncology coding team will review a sample of your recent encounters.

FAQs:

1. What are the initial service CPT codes for chemotherapy administration?

The initial service CPT codes include 96360, 96365, 96374, 96409, and 96413. Only one can be reported unless separate IV access sites are used.

2. Can I report CPT code 99211 with chemotherapy administration codes?

No, CPT code 99211 is included in the chemotherapy administration codes. Other E&M codes may be reported separately with modifier 25 if a significant service is provided.

3. Is flushing a vascular access port reportable separately?

No, flushing an implanted vascular access port is integral to the drug administration service and should not be reported separately.

4. What does CPT code 96522 cover?

CPT code 96522 covers the refilling and maintenance of an implantable pump for systemic drug delivery. It should not be used for non-programmable devices.

5. Can I report CPT code 96368 for concurrent infusions?

Yes, CPT code 96368 can be reported for a concurrent infusion of antiemetics with chemotherapy. Only one unit may be reported per encounter, regardless of the number of drugs.

6. What is the difference between CPT 96413 and 96415?

96413 reports the first hour of a chemotherapy infusion and needs more than 15 minutes of documented infusion time. +96415 is an add-on for each additional hour and is billed only when the infusion runs more than 30 minutes past the hour, so the first unit applies at 91 minutes.

7. When is CPT 96417 reported instead of 96415?

+96417 is reported when a second, different chemotherapy drug is infused sequentially after the first, covering up to one hour of that second drug. +96415 is used for extra hours of the same drug, including time beyond the first hour of the second drug.

8. Which ICD-10 code is listed first for a chemotherapy visit?

When the encounter is solely for chemotherapy, Z51.11 is listed first, followed by the active cancer diagnosis. For immunotherapy, Z51.12 is used. If a complication like dehydration is the main reason and no chemotherapy is given, the complication is sequenced first.

Sources:

Related Posts

888-357-3226